Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma

MLA

Steven C. Goldstein, et al. “Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma.” Biology of Blood and Marrow Transplantation, vol. 15, no. 1, Jan. 2009, pp. 109–17. EBSCOhost, https://doi.org/10.1016/j.bbmt.2008.11.011.

APA

Steven C. Goldstein, Jeanette Carreras, Vikas Gupta, Christopher Bredeson, Sergio Giralt, David I. Marks, Julie M. Vose, John Gibson, Robert Peter Gale, Cesar O. Freytes, Marcel P. Devetten, Parameswaran Hari, Koen van Besien, Paolo Anderlini, Richard T. Maziarz, Brent R. Logan, & Hillard M. Lazarus. (2009). Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation, 15(1), 109–117. https://doi.org/10.1016/j.bbmt.2008.11.011

Chicago

Steven C. Goldstein, Jeanette Carreras, Vikas Gupta, Christopher Bredeson, Sergio Giralt, David I. Marks, Julie M. Vose, et al. 2009. “Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma.” Biology of Blood and Marrow Transplantation 15 (1): 109–17. doi:10.1016/j.bbmt.2008.11.011.